Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1-dichloroethene | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of PI4K2B mRNA | CTD | PMID:26682919 | 1,2-dichloroethane | decreases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PI4K2B mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | multiple interactions | ISO | Pi4k2b (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PI4K2B mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Pi4k2b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PI4K2B promoter] | CTD | PMID:19654925 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PI4K2B mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PI4K2B mRNA | CTD | PMID:22808131 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PI4K2B mRNA | CTD | PMID:21570461 | 2,6-dinitrotoluene | affects expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of PI4K2B mRNA | CTD | PMID:21346803 | 4,4'-diaminodiphenylmethane | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of PI4K2B mRNA | CTD | PMID:18648102 | 4-hydroxyphenyl retinamide | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Fenretinide results in increased expression of PI4K2B mRNA | CTD | PMID:28973697 | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of PI4K2B protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of PI4K2B mRNA | CTD | PMID:19770486 | aflatoxin M1 | decreases expression | EXP | | 6480464 | Aflatoxin M1 results in decreased expression of PI4K2B mRNA | CTD | PMID:30928695 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of PI4K2B mRNA | CTD | PMID:33212167 | arsane | decreases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Arsenic results in decreased expression of PI4K2B mRNA | CTD | PMID:19654921 | arsenic atom | decreases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Arsenic results in decreased expression of PI4K2B mRNA | CTD | PMID:19654921 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of PI4K2B mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of PI4K2B mRNA | CTD | PMID:22228805 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of PI4K2B mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | ISO | Pi4k2b (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of PI4K2B intron | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of PI4K2B mRNA | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of PI4K2B mRNA | CTD | PMID:28085963 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Pi4k2b (Mus musculus) | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of PI4K2B mRNA] | CTD | PMID:19850644 | bisphenol A | multiple interactions | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of PI4K2B mRNA | CTD | PMID:26496021 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of PI4K2B gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PI4K2B gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PI4K2B mRNA | CTD | PMID:32145629 | bisphenol A | increases methylation | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of PI4K2B gene | CTD | PMID:28505145 | cadmium dichloride | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of PI4K2B mRNA | CTD | PMID:20883709 | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of PI4K2B protein | CTD | PMID:35688186 | carbon nanotube | decreases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PI4K2B gene] | CTD | PMID:28238834 | chlordecone | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Chlordecone results in increased expression of PI4K2B mRNA | CTD | PMID:33711761 | chlorpyrifos | decreases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of PI4K2B mRNA | CTD | PMID:37019170 | chromium(6+) | affects expression | ISO | Pi4k2b (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of PI4K2B mRNA | CTD | PMID:28472532 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of PI4K2B mRNA | CTD | PMID:27594783 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of PI4K2B mRNA | CTD | PMID:19320972 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of PI4K2B mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of PI4K2B mRNA | CTD | PMID:20106945 | dibutyl phthalate | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of PI4K2B mRNA | CTD | PMID:21266533 | dibutyl phthalate | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of PI4K2B mRNA | CTD | PMID:21266533 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of PI4K2B mRNA | CTD | PMID:28302478 | dioxygen | multiple interactions | ISO | Pi4k2b (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PI4K2B mRNA | CTD | PMID:30529165 | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of PI4K2B mRNA | CTD | PMID:18175754 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PI4K2B mRNA | CTD | PMID:27188386 | endosulfan | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of PI4K2B mRNA | CTD | PMID:29391264 | finasteride | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of PI4K2B mRNA | CTD | PMID:24136188 | fluoranthene | multiple interactions | ISO | Pi4k2b (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of PI4K2B mRNA | CTD | PMID:28329830 | flutamide | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of PI4K2B mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Pi4k2b (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PI4K2B mRNA | CTD | PMID:22206623 | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of PI4K2B protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PI4K2B gene | CTD | PMID:31601247 | gentamycin | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of PI4K2B mRNA | CTD | PMID:33387578 | inulin | multiple interactions | ISO | Pi4k2b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PI4K2B mRNA | CTD | PMID:36331819 | methoxychlor | affects methylation | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of PI4K2B gene | CTD | PMID:35440735 | nefazodone | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of PI4K2B mRNA | CTD | PMID:24136188 | nimesulide | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | nimesulide results in increased expression of PI4K2B mRNA | CTD | PMID:24136188 | oxaliplatin | multiple interactions | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of PI4K2B mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Pi4k2b (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PI4K2B mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PI4K2B mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Acetaminophen affects the expression of PI4K2B mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of PI4K2B mRNA | CTD | PMID:33387578 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of PI4K2B mRNA | CTD | PMID:22230336 | paraquat | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of PI4K2B mRNA | CTD | PMID:32680482 | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of PI4K2B mRNA | CTD | PMID:27153767 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Pi4k2b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PI4K2B mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PI4K2B mRNA | CTD | PMID:36331819 | phenobarbital | multiple interactions | ISO | Pi4k2b (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PI4K2B mRNA] | CTD | PMID:19482888 | phenobarbital | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Phenobarbital results in increased expression of PI4K2B mRNA | CTD | PMID:19270015 and PMID:19482888 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PI4K2B mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | pirinixic acid results in increased expression of PI4K2B mRNA | CTD | PMID:17426115 and PMID:18301758 | propiconazole | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | propiconazole results in increased expression of PI4K2B mRNA | CTD | PMID:21278054 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of PI4K2B mRNA and Resveratrol binds to and results in decreased activity of PI4K2B protein | CTD | PMID:16102733 and PMID:23557933 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PI4K2B mRNA | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | sodium arsenite results in increased expression of PI4K2B mRNA | CTD | PMID:20883709 and PMID:36209798 | sulindac | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Sulindac results in increased expression of PI4K2B mRNA | CTD | PMID:24136188 | testosterone | multiple interactions | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of PI4K2B mRNA | CTD | PMID:26496021 | testosterone | decreases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Testosterone deficiency results in decreased expression of PI4K2B mRNA | CTD | PMID:33848595 | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of PI4K2B mRNA | CTD | PMID:33359661 | tetrachloromethane | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of PI4K2B mRNA | CTD | PMID:27339419 and PMID:31919559 | thioacetamide | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of PI4K2B mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of PI4K2B mRNA | CTD | PMID:23557971 | topotecan | multiple interactions | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of PI4K2B mRNA | CTD | PMID:25729387 | trichloroethene | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of PI4K2B mRNA | CTD | PMID:33387578 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of PI4K2B mRNA | CTD | PMID:28818685 | valdecoxib | increases expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | valdecoxib results in increased expression of PI4K2B mRNA | CTD | PMID:24136188 | valproic acid | increases expression | ISO | Pi4k2b (Mus musculus) | 6480464 | Valproic Acid results in increased expression of PI4K2B mRNA | CTD | PMID:20546886 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PI4K2B mRNA | CTD | PMID:27188386 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PI4K2B mRNA | CTD | PMID:24383497 and PMID:26272509 | vinclozolin | affects expression | ISO | Pi4k2b (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of PI4K2B mRNA | CTD | PMID:19015723 | |